EWTX261016C00042000
EWTX Oct 16 2026 42.00 Call
optionOPRA
EODOct 2, 2026
2.00USD+42.857%(+0.60)7Vol273OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
42
Expiration
Oct 16, 2026
DTE
9d
Moneyness
OTM
Intrinsic
$0.00
EWTX 42 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $2.00 | +42.86% | 7 | 273 |
| Nov 20, 2026 | 44d | — | — | 0 | 0 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | — | — | 0 | 0 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | — | — | 0 | 0 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Nearby Strikes · Oct 16, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 36 C | $8.30 | +0.00% | 1 | 1 | ITM |
| 37 C | $7.80 | -6.02% | 1 | 4 | ITM |
| 38 C | $2.90 | -21.62% | 1 | 24 | ITM |
| 39 C | — | — | 0 | 0 | ITM |
| 40 C | $2.10 | -19.54% | 5 | 150 | OTM |
| 41 C | $2.36 | +0.00% | 1 | 1 | OTM |
| 42 C | $2.00 | +42.86% | 7 | 273 | OTM |
| 43 C | $1.40 | -62.06% | 1 | 2 | OTM |
| 44 C | $1.43 | -55.31% | 5 | 56 | OTM |
| 45 C | $1.00 | -9.09% | 12 | 105 | OTM |
| 46 C | $0.70 | +4.48% | 1 | 110 | OTM |
| 47 C | $0.89 | -57.62% | 1 | 21 | OTM |
| 48 C | $2.40 | -20.00% | 25 | 25 | OTM |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.